BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31577977)

  • 21. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells.
    Cumaoglu A; Dayan S; Agkaya AO; Ozkul Z; Ozpozan NK
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):413-9. PubMed ID: 25198886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new [1,2,4] Triazolo[1,5-a]Pyrimidine derivatives that Kill gastric cancer cells via the mitochondria pathway.
    Wang S; Ma XB; Yuan XH; Yu B; Xu YC; Liu HM
    Eur J Med Chem; 2020 Oct; 203():112630. PubMed ID: 32683165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors.
    Wang S; Guan L; Zang J; Xing K; Zhang J; Liu D; Zhao L
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
    Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
    Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
    Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro antiproliferative evaluation of some B-norcholesteryl Benzimidazole and Benzothiazole derivatives.
    Cui J; Qi B; Gan C; Liu Z; Huang H; Lin Q; Zhao D; Huang Y
    Mar Drugs; 2015 Apr; 13(4):2488-504. PubMed ID: 25913705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
    Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.
    Zhou B; Liu ZF; Deng GG; Chen W; Li MY; Yang LJ; Li Y; Yang XD; Zhang HB
    Org Biomol Chem; 2016 Oct; 14(39):9423-9430. PubMed ID: 27714171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of new sarsasapogenin derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells.
    Wang W; Wang D; Wang Z; Yao G; Li X; Gao P; Li L; Zhang Y; Wang S; Song S
    Eur J Med Chem; 2017 Feb; 127():62-71. PubMed ID: 28038327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents.
    Chen JN; Wang XF; Li T; Wu DW; Fu XB; Zhang GJ; Shen XC; Wang HS
    Eur J Med Chem; 2016 Jan; 107():12-25. PubMed ID: 26560049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
    Yurttaş L; Çiftçi GA
    Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K.
    Li ED; Lin Q; Meng YQ; Zhang LY; Song PP; Li N; Xin JC; Yang P; Bao CN; Zhang DQ; Zhang Y; Wang JK; Zhang QR; Liu HM
    Eur J Med Chem; 2019 Jun; 172():36-47. PubMed ID: 30939352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
    Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.